About Shionogi Inc.
Shionogi Inc. is the U.S.-based group company of Shionogi & Co., Ltd., a leading Japanese pharmaceutical company. Shionogi Inc, develops and commercializes pharmaceutical products that address unmet medical needs.
Shionogi Inc.’s products in development seek to help patients with a variety of diseases and conditions, including male sexual health, pediatric conditions, women’s health, HIV, and
obesity. learn more about us
Our Products
Shionogi Inc.’s portfolio includes products for cardiovascular disease, diabetes, pediatric conditions, and women’s
health. more
Product Pipeline
View our product pipeline, featuring a wide range of product candidates across each phase of development. more
Shionogi News
08/31/10
Shionogi Announces Positive Outcome to the Decentralized Procedure for the European Approval of TWINJECT® (EPINEPHRINE AUTO-INJECTOR) more
07/29/10
Shionogi Inc. Announces FDA Approval of CUVPOSA™ for the Treatment of Chronic Severe Drooling in Pediatric Patients with Neurologic Conditions more
07/22/10
Shionogi-ViiV Healthcare LLC Presents Positive Data on Investigational Once-Daily Integrase Inhibitor at International AIDS Conference more